|
Market Closed -
NSE India S.E.
04:35:08 18/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,447.40 INR | +1.30% |
|
+1.34% | +20.25% |
| 11/09 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 07/09 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
Chart: Technical Analysis
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 2,515 | 2,515 | 2,515 |
| Spread/Res. | -2.69% | -2.69% | -2.69% |
| Spread/Supp. | +6.17% | +6.17% | +13.60% |
| Support | 2,305.1 | 2,305.1 | 2,154.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GLENMARK Stock
- Charts Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
